ImmunoCellular Therapeutics, Ltd.
General ticker "IMUC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $14.1M (TTM average)
ImmunoCellular Therapeutics, Ltd. does not follow the US Stock Market performance with the rate: -11.5%.
Estimated limits based on current volatility of 1.8%: low 0.19$, high 0.20$
Factors to consider:
- Total employees count: 4 as of 2017
- Top business risk factors: Insufficient funding, Operational and conduct risks, Economic downturns and volatility, Market competition, Regulatory and compliance
Short-term IMUC quotes
Long-term IMUC plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $2.01MM |
| Operating Income | $-2.01MM |
| Non-Operating Income | $0.11MM |
| Interest Expense | $0.96MM |
| R&D Expense | $0.94MM |
| Income(Loss) | $-1.89MM |
| Profit(Loss)* | $-1.89MM |
| Stockholders Equity | $-0.62MM |
| Assets | $0.39MM |
| Operating Cash Flow | $-2.68MM |
| Capital expenditure | $0.00MM |
| Financing Cash Flow | $2.50MM |
| Earnings Per Share** | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.